MedPath

Metronidazole

Generic Name
Metronidazole
Brand Names
Flagyl, Flagystatin, Likmez, Metrocream, Metrogel, Metrolotion, Nidagel, Noritate, Nuvessa, Pylera, Rosadan, Vandazole
Drug Type
Small Molecule
Chemical Formula
C6H9N3O3
CAS Number
443-48-1
Unique Ingredient Identifier
140QMO216E
Background

Metronidazole is a commonly used antibiotic, belonging to the nitroimidazole class of antibiotics. It is frequently used to treat gastrointestinal infections as well as trichomoniasis and giardiasis, and amebiasis which are parasitic infections. Metronidazole has been used as an antibiotic for several decades, with added antiparasitic properties that set it apart from many other antibacterial drugs, allowing it to treat a wide variety of infections. It is available in capsule form, tablet form, and topical form, and suppository preparations for the treatment of various infections.

Indication

Metronidazole is indicated for the treatment of confirmed trichomoniasis caused by Trichomonas vaginalis (except for in the first trimester of pregnancy) and the patient's sexual partners, bacterial vaginosis, certain types of amebiasis, and various anaerobic infections. The above anaerobic infections may occur on the skin and skin structures, the abdomen, the heart, reproductive organs, central nervous system, and the respiratory system. Some may also be present in the bloodstream in cases of septicemia. Common infections treated by metronidazole are Bacteroides species infections, Clostridium infections, and Fusobacterium infections, as well as Peptococcus and Peptostreptococcus infections. Topical formulations of metronidazole are indicated for the treatment of inflammatory lesions of rosacea.

It is also used off-label in the treatment of Crohn's disease, as a prophylactic agent after surgery, and in the treatment of Helicobacter pylori infection. It has also been studied in the prevention of preterm births and to treat periodontal disease.

Associated Conditions
Abscess Brain, Abscess, Intra-Abdominal, Anaerobic Bacterial Infection, Bacterial Endocarditis, Bacterial Peritonitis, Bacterial Septicemia, Bacterial Vaginosis (BV), Balantidiasis, Bone and Joint Infections, Central Nervous System Bacterial Infections, Empyema, Endometritis, Endomyometritis, Facial Rosacea, Giardiasis, Gynecological Infection, Helicobacter Pylori Infection, Inflammatory Papule, Inflammatory pustules, Liver Abscess, Amebic, Lower respiratory tract infection bacterial, Lung Abscess, Meningitis, Mixed Vaginal Infections, Mixed Vaginal Infections caused by Trichomonas Vaginalis, candida albicans, Periodontitis, Pneumonia, Postoperative Infections, Pouchitis, Skin and skin structure infections, Tetanus, Trichomonas Vaginitis, Tubo-ovarian abscess, Vaginal Candidiasis, Vaginitis Trichomonal, Vulvovaginitis, Acute Intestinal amebiasis, Asymptomatic Trichomoniasis, Entamoeba histolytica, Hepatic abscess, Intra-abdominal bacterial infections, Post-surgical vaginal cuff infection, Refractory Sinusitis, Symptomatic Trichomoniasis
Associated Therapies
-

Response of Clostridium Difficile Infection to Metronidazole Therapy

Completed
Conditions
Clostridium Enterocolitis
Pseudomembranous Colitis
Antibiotic-Associated Colitis
First Posted Date
2006-03-17
Last Posted Date
2013-02-18
Lead Sponsor
Michael E. DeBakey VA Medical Center
Target Recruit Count
290
Registration Number
NCT00304369
Locations
🇺🇸

Michael E. Debakey VA Medical Center, Houston, Texas, United States

Study of Antibiotics in the Treatment of Colonic Crohn's Disease

First Posted Date
2005-11-23
Last Posted Date
2008-08-12
Lead Sponsor
Mount Sinai Hospital, Canada
Target Recruit Count
12
Registration Number
NCT00257699
Locations
🇨🇦

Mount Sinai Hospital, Toronto, Ontario, Canada

Helicobacter - Lymphoma - Radiation Part I: Eradication, Part II: Radiation

Phase 3
Conditions
Lymphoma
Lymphoma, Non-Hodgkin
First Posted Date
2005-09-12
Last Posted Date
2007-03-26
Lead Sponsor
Technische Universität Dresden
Target Recruit Count
200
Registration Number
NCT00154440
Locations
🇩🇪

Institute for Pathology, Bayreuth, Bavaria, Germany

🇩🇪

Dept. for Radiation Therapy & Radiooncology, University Hospital, Germany, Saxonia, Germany

🇩🇪

Med. Dept. I, Gastroenterology, Dresden, Saxonia, Germany

Effect of Three Periodontal Therapies in Current Smokers and Non-Smokers

Phase 2
Completed
Conditions
Periodontitis
Periodontal Diseases
Interventions
First Posted Date
2003-08-05
Last Posted Date
2013-04-22
Lead Sponsor
The Forsyth Institute
Target Recruit Count
146
Registration Number
NCT00066066
Locations
🇺🇸

Department of Periodontology, Cambridge, Massachusetts, United States

Microbial Associations in Periodontal Health and Disease

Phase 2
Completed
Conditions
Periodontitis
Periodontal Diseases
Interventions
First Posted Date
2003-08-05
Last Posted Date
2010-11-09
Lead Sponsor
The Forsyth Institute
Target Recruit Count
154
Registration Number
NCT00066001
Locations
🇺🇸

Department of Periodontology, The Forsyth Institute, Boston, Massachusetts, United States

Antibiotics to Reduce Chorioamnionitis-Related Perinatal HIV Transmission

Phase 3
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-11-01
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
3720
Registration Number
NCT00021671
Locations
🇺🇸

Megan Valentine, Research Triangle Park, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath